Category: Regulatory

What is an Investigator’s Brochure (IB)? Clinical trials are the foundation of pharmaceutical innovation, and their success depends on clear communication between sponsors and investigators. The Investigator’s Brochure (IB) is a critical document that provides comprehensive information about an investigational product, ensuring that clinical trial teams understand its properties, risks, and potential benefits. It serves… Continue reading What is an Investigator’s Brochure (IB)?

What is Document Management System (DMS)? In the pharmaceutical industry, documentation is the backbone of compliance, quality assurance, and regulatory approval. Every stage of drug development—from research to manufacturing—requires meticulous records.

What is a Regulatory Gap Analysis? In the pharmaceutical industry, compliance with evolving global regulations is critical to ensure patient safety, product quality, and uninterrupted market access. A Regulatory Gap Analysis is a systematic process used by pharma companies to identify discrepancies between current practices and regulatory requirements.

What Is a Regulatory Dossier? In the pharmaceutical industry, the development and approval of medicinal products depend heavily on the quality and completeness of regulatory documentation. One of the most critical components of this documentation is the regulatory dossier.

What is a Certificate of Free Sale (CFS)? In the pharmaceutical industry, international trade requires strict documentation to ensure product safety and compliance. One of the most important documents for exporting medicines and healthcare products is the Certificate of Free Sale (CFS).

What is a Regulatory Submission? In the pharmaceutical industry, bringing a new drug or medical product to market requires strict adherence to global regulatory standards. A regulatory submission is the formal process by which pharmaceutical companies present comprehensive data packages to health authorities, such as the U.S. Food and Drug Administration (FDA), the European Medicines… Continue reading What is a Regulatory Submission?

What is Regulatory Intelligence in Pharma? Regulatory intelligence (RI) has become a cornerstone for pharmaceutical companies navigating the highly regulated global landscape. It refers to the systematic process of gathering, analyzing, and applying information about current and emerging regulations, guidelines, and industry standards to ensure compliance, accelerate product development, and support market access.

What is Regulatory Compliance? Regulatory compliance in the pharmaceutical industry is the conformity to the laws, guidelines and standards that are set by the authorities that control the safety, efficacy and quality of pharmaceutical products. The regulations protect the health of the population as stringent control can be maintained during the design of the drug,… Continue reading What is Regulatory Compliance?

Streamlining Change: New EU Guidelines Simplify Medicines Lifecycle Management EMA welcomes the publication of the European Commission’s (EC) new Variations Guidelines, which streamline the lifecycle management of medicines (see EC news). These EU Variation guidelines will support the implementation of the new Variations Regulation that came into force in 15 January 2025.

Changes to e-Submission Requirements for CEP Applications As part of continuous digital transformation in regulatory processes, the European Directorate for the Quality of Medicines & HealthCare (EDQM) has introduced automation to enhance the management and review of Certificates of Suitability to the Monographs of the European Pharmacopoeia (CEP) submissions.